A cholesterol breakthrough medication just became available. Lipfendra (enlicitide) is a groundbreaking prescription medication from Merck that was approved by the FDA in July 2026 as the world's first once-daily oral pill to lower bad cholesterol (LDL-C). It works by blocking the PCSK9 protein, which helps the liver aggressively clear cholesterol from the bloodstream. This daily tablet offers a highly effective, needle-free alternative for patients who previously had to rely on painful bi-weekl

Soft Plaque vs Hard Plaque: Why the Difference Matters

Immersive Medicine First-Person: IV Serum and Nursing Care

Clinical diagnostic testing explained: common tests and what they mean

Day in the Life: Labor and Delivery Midwife Work Vlog

Sepsis clinical scenario for nursing students